Non-small Cell Lung Cancer Stage IIIC
Oncology·MeSH: Carcinoma, Non-Small-Cell Lung
Prevalence
75.0 / 100K
Incidence
47.0 / 100K/yr
0 drugs in development·0 companies·0 clinical trials
Deep-dive into Non-small Cell Lung Cancer Stage IIIC
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis